Priv.-Doz. Dr. med. Jan H. Terheyden, FEBO
Advertisement
Articles by Priv.-Doz. Dr. med. Jan H. Terheyden, FEBO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA requires NAION warning across the GLP-1 receptor agonist class
2
Anti-VEGF switches for persistent fluid: A review of 3 clinical cases
3
City Therapeutics doses first participant in phase 1 trial of RNAi therapy CITY-RBP4 for Stargardt disease
4
Longer anti-VEGF intervals in AMD, BRVO, and DME: 3 clinical cases
5